Search Results - "Rosenberg, Zale"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Treatment Discontinuation and Clinical Events in Type 2 Diabetes Patients Treated with Dipeptidyl Peptidase-4 Inhibitors or NPH Insulin as Third-Line Therapy by Behlouli, Hassan, Bernatsky, Sasha, Abrahamowicz, Michal, Rosenberg, Zale B., Moura, Cristiano S., Pilote, Louise

    Published in Journal of diabetes research (01-01-2018)
    “…Objective. To compare dipeptidyl peptidase-4 (DPP-4) inhibitors with neutral protamine Hagedorn (NPH) insulin, in terms of effectiveness and safety for the…”
    Get full text
    Journal Article
  2. 2

    Survey of smokers' reasons for not switching to safer sources of nicotine and their willingness to do so in the future by Heavner, Karyn K, Rosenberg, Zale, Phillips, Carl V

    Published in Harm reduction journal (02-07-2009)
    “…Despite the well-known risks of smoking, policy, social pressure, and accessible cessation programs, tens of millions of North American adults continue smoking…”
    Get full text
    Journal Article
  3. 3

    Retailers' knowledge of tobacco harm reduction following the introduction of a new brand of smokeless tobacco by Heavner, Karyn K, Rosenberg, Zale, Tenorio, Francis, Phillips, Carl V

    Published in Harm reduction journal (29-07-2010)
    “…Tobacco retailers are potential public health partners for tobacco harm reduction (THR). THR is the substitution of highly reduced-risk nicotine products, such…”
    Get full text
    Journal Article